Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ebinger

Showing results (211-220 of 258) with videos related to

Pageof 26
Sort By:
Cancer Medicine|February 21, 2026
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT)Ajla T Wasti, Gianni Bisogno, Beatrice Coppadoro, et al.
Human Brain Mapping|September 14, 2022
Early effect of thrombolysis on structural brain network organisation after anterior-circulation stroke in the randomized WAKE-UP trialEckhard Schlemm, Märit Jensen, Amy Kuceyeski, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 12, 2011
Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformationBruce C V Campbell, Craig Costello, Søren Christensen, et al.
Cancer Research|October 28, 2025
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial EpendymomaErik Schüftan, I-Na Lu, Flavia W de Faria, et al.
JAMA Neurology|March 26, 2019
Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP TrialEwgenia Barow, Florent Boutitie, Bastian Cheng, et al.
Neurological Research and Practice|December 16, 2020
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trialBenedikt M Frey, Florent Boutitie, Bastian Cheng, et al.
The Lancet. Oncology|December 9, 2019
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trialBirgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, et al.
Pediatric Blood & Cancer|October 4, 2021
Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastomaLea Grümme, Eva Biewald, Madlen Reschke, et al.
Journal for Immunotherapy of Cancer|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohortAnna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Blood|August 2, 2019
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesisTatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, et al.
Pageof 26

Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Cancer Medicine|February 21, 2026
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT)Ajla T Wasti, Gianni Bisogno, Beatrice Coppadoro, et al.
Human Brain Mapping|September 14, 2022
Early effect of thrombolysis on structural brain network organisation after anterior-circulation stroke in the randomized WAKE-UP trialEckhard Schlemm, Märit Jensen, Amy Kuceyeski, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 12, 2011
Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformationBruce C V Campbell, Craig Costello, Søren Christensen, et al.
Cancer Research|October 28, 2025
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial EpendymomaErik Schüftan, I-Na Lu, Flavia W de Faria, et al.
JAMA Neurology|March 26, 2019
Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP TrialEwgenia Barow, Florent Boutitie, Bastian Cheng, et al.
Neurological Research and Practice|December 16, 2020
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trialBenedikt M Frey, Florent Boutitie, Bastian Cheng, et al.
The Lancet. Oncology|December 9, 2019
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trialBirgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, et al.
Pediatric Blood & Cancer|October 4, 2021
Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastomaLea Grümme, Eva Biewald, Madlen Reschke, et al.
Journal for Immunotherapy of Cancer|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohortAnna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Blood|August 2, 2019
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesisTatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, et al.
Pageof 26